tiprankstipranks
Trending News
More News >
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY

Sonova Holding AG (SONVY) Price & Analysis

Compare
31 Followers

SONVY Stock Chart & Stats

$50.26
-$0.29(-0.44%)
At close: 4:00 PM EST
$50.26
-$0.29(-0.44%)

Sonova Holding AG News

SONVY FAQ

What was Sonova Holding AG Unsponsored ADR’s price range in the past 12 months?
Sonova Holding AG Unsponsored ADR lowest stock price was $48.08 and its highest was $71.02 in the past 12 months.
    What is Sonova Holding AG Unsponsored ADR’s market cap?
    Sonova Holding AG Unsponsored ADR’s market cap is $15.35B.
      When is Sonova Holding AG Unsponsored ADR’s upcoming earnings report date?
      Sonova Holding AG Unsponsored ADR’s upcoming earnings report date is May 19, 2026 which is in 156 days.
        How were Sonova Holding AG Unsponsored ADR’s earnings last quarter?
        Sonova Holding AG Unsponsored ADR released its earnings results on Nov 14, 2025. The company reported $0.897 earnings per share for the quarter, missing the consensus estimate of $0.982 by -$0.085.
          Is Sonova Holding AG Unsponsored ADR overvalued?
          According to Wall Street analysts Sonova Holding AG Unsponsored ADR’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sonova Holding AG Unsponsored ADR pay dividends?
            Sonova Holding AG Unsponsored ADR pays a Annually dividend of $1.077 which represents an annual dividend yield of 2.16%. See more information on Sonova Holding AG Unsponsored ADR dividends here
              What is Sonova Holding AG Unsponsored ADR’s EPS estimate?
              Sonova Holding AG Unsponsored ADR’s EPS estimate is 1.42.
                How many shares outstanding does Sonova Holding AG Unsponsored ADR have?
                Sonova Holding AG Unsponsored ADR has 298,134,030 shares outstanding.
                  What happened to Sonova Holding AG Unsponsored ADR’s price movement after its last earnings report?
                  Sonova Holding AG Unsponsored ADR reported an EPS of $0.897 in its last earnings report, missing expectations of $0.982. Following the earnings report the stock price went down -7.158%.
                    Which hedge fund is a major shareholder of Sonova Holding AG Unsponsored ADR?
                    Currently, no hedge funds are holding shares in SONVY

                    Sonova Holding AG Stock Smart Score

                    3
                    Underperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Technicals

                    SMA
                    Negative
                    20 days / 200 days
                    Momentum
                    -26.09%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    21.18%
                    Trailing 12-Months
                    Asset Growth
                    4.13%
                    Trailing 12-Months

                    Company Description

                    Sonova Holding AG Unsponsored ADR

                    Sonova Holding AG is a global leader in the design and manufacturing of hearing care solutions, headquartered in Switzerland. The company operates primarily in the healthcare sector, focusing on the development of innovative hearing aids, cochlear implants, and related services. With a strong commitment to improving the quality of life for individuals with hearing loss, Sonova offers a wide range of products through its various brands, including Phonak, Unitron, and Advanced Bionics.

                    Sonova Holding AG (SONVY) Earnings & Revenues

                    SONVY Company Deck

                    SONVY Earnings Call

                    Q2 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call presented a strong performance in the larger business segments with significant market share gains, supported by successful product launches and innovation. However, challenges in smaller segments, currency headwinds, and a decline in gross margins were notable concerns. The outlook remains positive with growth expectations, but market volatility and currency impacts pose challenges.View all SONVY earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Insulet
                    Koninklijke Philips
                    Smith & Nephew Snats
                    Steris
                    Zimmer Biomet Holdings

                    Ownership Overview

                    1.03%<0.01%98.95%
                    Insiders
                    <0.01% Other Institutional Investors
                    98.95% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks